Senior Companion Program for Multiple Disabilities

Phase-Based Progress Estimates
University of Notre Dame, Notre Dame, IN
Multiple Disabilities+1 More
Senior Companion Program - Other
All Sexes
What conditions do you have?

Study Summary

Senior Companion Programs (SCP) facilitate partnerships between community volunteers and local homebound seniors. Seniors served by the SCP will be provided with a companion who will conduct weekly visits with them, help with meal preparation or deliveries, provide transportation, assist with simple housekeeping, and socialize with the client amongst other tasks. These services are directed towards helping the senior client continue living independently in their own home instead of moving into an assisted living or nursing home. The SCP model is being evaluated to determine the impact of the services on the client's overall well-being and independent living status.

Eligible Conditions

  • Multiple Disabilities
  • Aging

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: 6- and 18-months after study enrollment

6- and 18-months after study enrollment
Difference in mortality rates of between treatment and control groups
Difference in rates of self-reported independent living status between treatment and control groups
Difference in rates of self-reported life satisfaction between treatment and control groups
Difference in rates of self-reported loneliness between treatment and control groups
Self-reported physical and mental health

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
Senior Companion
1 of 2
Active Control
Experimental Treatment

1040 Total Participants · 2 Treatment Groups

Primary Treatment: Senior Companion Program · No Placebo Group · N/A

Senior Companion
Experimental Group · 1 Intervention: Senior Companion Program · Intervention Types: Other
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6- and 18-months after study enrollment
Closest Location: University of Notre Dame · Notre Dame, IN
Photo of indiana 1Photo of indiana 2Photo of indiana 3
2019First Recorded Clinical Trial
1 TrialsResearching Multiple Disabilities
1 CompletedClinical Trials

Who is running the clinical trial?

Catholic Charities of Southeast MichiganUNKNOWN
Positive Maturity, Inc.UNKNOWN
The Evangelical Lutheran Good Samaritan SocietyUNKNOWN
William EvansLead Sponsor
Georgia Southern UniversityOTHER
4 Previous Clinical Trials
1,040 Total Patients Enrolled
Health Association of Niagara County, Inc.UNKNOWN
William N Evans, PhDPrincipal InvestigatorUniversity of Notre Dame
Sarah Kroeger, PhDPrincipal InvestigatorUniversity of Notre Dame

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.